What is Steris Price-to-Operating-Cash-Flow?
As of today (2024-12-15), Steris's share price is $214.22.
Steris's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $11.08. Hence, Steris's Price-to-Operating-Cash-Flow Ratio for today is 19.34.
The historical rank and industry rank for Steris's Price-to-Operating-Cash-Flow or its related term are showing as below:
STE'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.17 Med: 21.87 Max: 36.1
Current: 19.34
During the past 13 years, Steris's highest Price-to-Operating-Cash-Flow Ratio was 36.10. The lowest was 13.17. And the median was 21.87.
Steris's Cash Flow from Operations per share for the
three
months ended in Sep. 2024 was $2.53.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $11.08.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Steris was 30.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.90% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.30% per year.
During the past 13 years, Steris's highest 3-Year average Operating Cash Flow per Share Growth Rate was 352.40% per year. The lowest was -64.70% per year. And the median was 7.70% per year.
Steris Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Steris's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris Price-to-Operating-Cash-Flow Chart
|
Steris Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
20.30 |
23.72 |
34.71 |
25.33 |
22.95 |
|
Steris Quarterly Data
|
|
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
25.85 |
23.47 |
22.95 |
21.91 |
21.90 |
Competitive Comparison of Steris's Price-to-Operating-Cash-Flow
For the Medical Devices subindustry, Steris's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Steris's Price-to-Operating-Cash-Flow falls into.
Steris Price-to-Operating-Cash-Flow Calculation
Steris's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 214.22 | / | 11.077 |
| = | 19.34 |
Steris's Share Price of today is $214.22.
Steris's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Steris Business Description
Traded in Other Exchanges
N/A
Address
5960 Heisley Road, Mentor, OH, USA, 44060
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Executives
| Cary L Majors |
officer: VP, N America Com Operations |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Michael J Tokich |
director, officer: Sr. Vice Pres., CFO |
C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060 |
| Christopher S Holland |
director |
ARAMARK CORP, 1101 MARKET ST 29TH FLOOR, PHILADELPHIA PA 19107 |
| Julia Madsen |
officer: Senior VP, Life Sciences |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Renato Tamaro |
officer: V.P. & Corporate Treasurer |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Cynthia L Feldmann |
director |
17 WINTHROP ROAD, WAYLAND MA 01778 |
| Mohsen Sohi |
director |
C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060 |
| Karen L Burton |
officer: VP, Controller & CAO |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Jacqueline B Kosecoff |
director |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Richard C Breeden |
director |
100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606 |
| Esther M. Alegria |
director |
2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
| John Adam Zangerle |
director, officer: Sr. VP, Gen Counsel, and Sec. |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Andrew Xilas |
officer: SVP and GM, Dental |
5960 HEISLEY ROAD, MENTOR OH 44060 |
| Paul Edward Martin |
director |
C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422 |
| David B Lewis |
director |
|
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STE has been successfully added to your